Search

Showing total 99 results

Search Constraints

Start Over You searched for: Topic cirrhosis of the liver Remove constraint Topic: cirrhosis of the liver Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years Journal alimentary pharmacology & therapeutics Remove constraint Journal: alimentary pharmacology & therapeutics Database Academic Search Index Remove constraint Database: Academic Search Index Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
99 results

Search Results

1. Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply.

3. Practical considerations for fluid resuscitation in cirrhosis.

4. Editorial: Are glucagon‐like peptide‐1 receptor agonists the functional cure for patients with metabolic dysfunction‐associated cirrhosis?

5. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find. Author's reply.

6. Letter: Shorter duration of intravenous terlipressin for variceal bleeding in patients with cirrhosis—A promising find.

10. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D—Authors' reply.

11. Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D.

12. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed. Authors' reply.

13. Letter: Association of polymorphic variant of SerpinB3 and faster cirrhosis decompensation in patients with cirrhosis—More evidence needed.

14. Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels—authors' reply.

15. Letter: Severe underweight and sarcopenia in decompensated cirrhosis are associated with high FGF21 levels.

17. Letter: Exploring the clinical utility of ammonia in critically ill patients with cirrhosis: More to do? Authors' reply.

19. Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.

24. Letter: the diagnostic value of ultrasound‐based versus CT‐based sarcopenia measurement in cirrhosis.

25. Letter: improved alanine aminotransferase level in patients with chronic hepatitis B without cirrhosis and low viral load treated with nucleotide/nucleoside analogues.

26. Letter: improve survival in variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed. Authorsʼ reply.

27. Letter: improve survival after variceal bleeding in cirrhosis—place pTIPS as early as possible after index bleed.

28. The association between hepatocellular carcinoma and direct‐acting anti‐viral treatment in patients with decompensated cirrhosis.

29. Letter: serum HBV RNA and HBcrAg may help to evaluate safely stopping nucleot(s)ide analogues in patients with HBeAg‐negative chronic hepatitis B and without cirrhosis.

30. Letter: hepatocellular carcinoma negatively affects sustained virological response of direct‐acting anti‐viral treatment in decompensated cirrhosis.

34. Letter: non‐selective beta‐blockers in cirrhosis—effect beyond portal hypertension. Authors' reply.

35. Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD—not everyone fits the mould. Authors' reply.

37. Letter: non‐invasive prediction models to exclude cirrhosis in NAFLD – not everyone fits the mould.

38. Editorial: screening for hepatocellular carcinoma in NAFLD cirrhosis—towards abbreviated MRI alternative in patients with obesity? Authors' reply.

40. Editorial: when to start carvedilol in cirrhosis—time to reconsider? Authors' reply.

42. Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis—authors' reply.

43. Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B‐related compensated cirrhosis.

47. Editorial: proton pump inhibitor use in cirrhosis—a piece of the puzzle. Authors' reply.

50. TIPSS and reversal of sarcopenia, and TIPSS is a promising therapy for sarcopenia in cirrhosis—Authors' reply.